Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals

被引:25
|
作者
Shafer, RW [1 ]
Warford, A [1 ]
Winters, MA [1 ]
Gonzales, MJ [1 ]
机构
[1] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
关键词
HIV-1; protease; reverse transcriptase;
D O I
10.1016/S0166-0934(00)00144-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The reproducibility of population-based human immunodeficiency virus type 1 (HIV-I) protease and reverse transcriptase (RT) sequencing was assessed using replicate aliquots of cryopreserved plasma samples obtained from seven heavily treated HIV-1-infected individuals. The sequence of each sample replicate was compared with the consensus sequence for that sample and 99.4% of 35128 amino acids were found to be concordant with the sample consensus. Partial discordances were present at 0.5% of positions and complete discordances were present at <0.1% of positions. To assess the reproducibility at detecting mutations (defined here as differences from the subtype B consensus sequence), the proportion of sequences having a mutation when at least two sequences from that sample had the same mutation were examined. There was a median of 13 protease and 18 RT mutations per sample for a total of 3126 mutations; 95% of these mutations were detected. However, sequencing of multiple clones from two samples demonstrated that those mutations present in a minority of clones were often not detected by population-based sequencing. These results suggest that HIV-I protease and RT sequencing of circulating plasma virus is highly reproducible but that the sensitivity at detecting mutations may be low if those mutations are present as minor variants. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 50 条
  • [31] Inhibition of HIV-1 protease and RNase H of HIV-1 reverse transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba
    Lee, Ji Suk
    Hattori, Masao
    Kim, Jinwoong
    PLANTA MEDICA, 2008, 74 (05) : 532 - 534
  • [32] Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women
    Min, SS
    Corbett, AH
    Rezk, N
    Cu-Uvin, S
    Fiscus, SA
    Petch, L
    Cohen, MS
    Kashuba, ADM
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (05) : 1577 - 1580
  • [33] Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients
    Elizabeth D. A. Wheeler
    Cristian L. Achim
    Velpandi Ayyavoo
    Journal of NeuroVirology, 2006, 12 : 200 - 210
  • [34] Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients
    Wheeler, Elizabeth D. A.
    Achim, Cristian L.
    Ayyavoo, Velpandi
    JOURNAL OF NEUROVIROLOGY, 2006, 12 (03) : 200 - 210
  • [35] Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testing
    Shao, XW
    Malmsten, A
    Lennerstrand, J
    Sönnerborg, A
    Unge, T
    Gronowitz, JS
    Källander, CFR
    AIDS, 2003, 17 (10) : 1463 - 1471
  • [36] Murine leukemia virus reverse transcriptase:: Structural comparison with HIV-1 reverse transcriptase
    Cote, Marie L.
    Roth, Monica J.
    VIRUS RESEARCH, 2008, 134 (1-2) : 186 - 202
  • [37] Unraveling the concerted catalytic mechanism of the human immunodeficiency virus type 1 (HIV-1) protease: a hybrid QM/MM study
    Lawal, Monsurat M.
    Sanusi, Zainab K.
    Govender, Thavendran
    Tolufashe, Gideon F.
    Maguire, Glenn E. M.
    Honarparvar, Bahareh
    Kruger, Hendrik G.
    STRUCTURAL CHEMISTRY, 2019, 30 (01) : 409 - 417
  • [38] Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton
    Bukrinskaya, A
    Brichacek, B
    Mann, A
    Stevenson, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) : 2113 - 2125
  • [39] Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease
    Hutoran, M
    Britan, E
    Baraz, L
    Blumenzweig, I
    Steinitz, M
    Kotler, M
    VIROLOGY, 2004, 330 (01) : 261 - 270
  • [40] Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations
    Shahriar, Rajin
    Rhee, Soo-Yon
    Liu, Tommy F.
    Fessel, W. Jeffrey
    Scarsella, Anthony
    Towner, William
    Holmes, Susan P.
    Zolopa, Andrew R.
    Shafer, Robert W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) : 4869 - 4878